Cumberland Pharmaceuticals Inc. Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award
Cumberland Pharmaceuticals Inc. (CPIX) reported Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award of 11.99 thousand shares for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward · last filed 2025-11-07
- Cumberland Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, shares purchased for award for the quarter ending 2025-09-30 was 6.49K shares, a 66.50% decline year-over-year.
- Cumberland Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, shares purchased for award for the quarter ending 2025-06-30 was 4.22K shares.
- Cumberland Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, shares purchased for award for the quarter ending 2025-03-31 was 1.28K shares.
- Cumberland Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, shares purchased for award for the quarter ending 2024-09-30 was 19.36K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award 9 month |
|---|---|---|---|
| 2025-09-30 | 6.49K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | 10.71K shares derived: sum of 2 quarters · filed 2025-11-07 | 11.99K shares 10-Q · filed 2025-11-07 |
| 2025-06-30 | 4.22K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | 5.50K shares 10-Q · filed 2025-08-08 | |
| 2025-03-31 | 1.28K shares 10-Q · filed 2025-05-09 | ||
| 2024-09-30 | 19.36K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | 22.89K shares 10-Q · filed 2024-11-08 | |
| 2024-06-30 | 3.53K shares 10-Q · filed 2024-08-09 | ||
| 2023-09-30 | 14.73K shares 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |